Related Experiment Videos
Coronary Revascularization in Patients with Acute Coronary Syndromes
1Director, Interventional Cardiology, Brigham and WomenÕs Hospital, 75 Francis Street, L-2 Cardiac Catheterization Laboratory, Boston, MA, 02115, USA. jjpopma@bics.bwh.harvard.edu
Insights
For acute coronary syndromes (ACS), judicious cardiac catheterization and revascularization can improve prognosis. Early intervention benefits high-risk patients, but routine revascularization outcomes are still under investigation.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Non-Q wave myocardial infarction and unstable angina are significant causes of morbidity and mortality in atherosclerotic coronary artery disease.
- Acute coronary syndromes (ACS) represent a critical challenge in cardiovascular medicine.
Purpose of the Study:
- To evaluate the role of judicious cardiac catheterization and coronary revascularization in improving prognosis for patients with ACS.
- To identify high-risk patient subgroups within ACS who may benefit from early invasive strategies.
Main Methods:
- Review of existing studies on cardiac catheterization and coronary revascularization in ACS.
- Analysis of patient subgroups based on electrocardiographic findings (ST-segment depression, left bundle branch block, T-wave inversion) and clinical indicators (recurrent pain, enzyme elevation, exercise-induced ischemia).
- Comparison of outcomes between routine invasive strategies and selective revascularization.
Main Results:
- High-risk ACS patients, identified by specific ECG changes or clinical signs, may benefit from early cardiac catheterization and revascularization.
- The benefit of routine coronary revascularization in all ACS patients is not definitively established, with conflicting results from previous studies.
- Ongoing trials, such as the TIMI-18 trial, are crucial for clarifying the optimal revascularization strategy.
Conclusions:
- A judicious, individualized approach to revascularization is warranted for patients presenting with ACS.
- Further research is needed to establish the definitive role and timing of routine coronary revascularization in ACS management.
- Identifying high-risk ACS patients is key to optimizing treatment strategies and improving patient outcomes.
Abstract:
Non-Q wave myocardial infarction and unstable angina remain major causes of morbidity and mortality in patients with atherosclerotic coronary artery disease. Judicious use of cardiac catheterization and coronary revascularization may further improve the prognosis of patients with these acute coronary syndromes (ACS). Patients with ACS at high risk for further cardiac events include those patients with electrocardiographic ST-segment depression, left bundle branch block, and, to a lesser extent, T-wave inversion, and those patients with recurrent pain, cardiac enzyme elevation, or exercise-induced ischemia after hospitalization. While these patient subgroups may benefit from early cardiac catheterization and revascularization, the role of routine coronary revascularization is less well established. Whereas one study has demonstrated reduced recurrent hospitalizations in patients treated with routine invasiveive strategy, another has suggested that outcomes are not different with the two approaches. Pending the results of a third ongoing study Ñ the Thrombolysis in Myocardial Infarction (TIMI)-18 trial Ñ a judicious approach to revascularization in patients presenting with ACS is warranted.